Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae

Protein Expression and Purification

Volumn 78, Issue 2, 2011, Pages 149-155

  Jung, Joohee ^a,c   Iijima, Masumi ^b   Yoshimoto, Nobuo ^b   Sasaki, Mano ^b   Niimi, Tomoaki ^b   Tatematsu, Kenji ^a   Jeong, Seong Yun ^c   Choi, Eun Kyung ^c,d   Tanizawa, Katsuyuki ^a   Kuroda, Shun'Ichi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c Asan Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Affinity column chromatography; Bio nanocapsules; DDS; GDS; Heat treatment; Hepatitis B virus surface antigen; Lyophilization; Yeast

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; LIPOSOME; NANOCAPSULE;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL STRAIN HEK293; CHEMISTRY; DRUG DELIVERY SYSTEM; FREEZE DRYING; GENE TRANSFER; HEAT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOUSE; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE;

ANIMALS; CHROMATOGRAPHY, AFFINITY; DRUG DELIVERY SYSTEMS; FREEZE DRYING; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HEPATITIS B SURFACE ANTIGENS; HOT TEMPERATURE; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; NANOCAPSULES; PROTEIN STABILITY; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE;

HEPATITIS B VIRUS; SACCHAROMYCES CEREVISIAE;

EID: 79958766291     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2011.04.008     Document Type: Article

References (27)

1. P. Tiollais, P. Christine, A. Dejean, The hepatitis B virus, Nature 317 (1985) 489-495. (Pubitemid 16224154)
2. K.H. Heermann, U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, W.H. Gerlich, Large surface proteins of hepatitis B virus containing the pre-S sequence, J. Virol. 52 (1984) 396-402. (Pubitemid 15202474)
3. H.J. Hong, C.J. Ryu, H. Hur, S. Kim, H.K. Oh, M.S. Oh, S.Y. Park, In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees, Virology 318 (2004) 134-141.
4. A.R. Neurath, S.B. Kent, N. Stick, K. Parker, Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus, Cell 46 (1986) 429-436. (Pubitemid 16031679)
5. S. Kuroda, S. Otaka, T. Miyazaki, M. Nakao, Y. Fujisawa, Hepatitis B virus envelope L protein particles, J. Biol. Chem. 267 (1992) 1953-1961.
6. T. Yamada, Y. Iwasaki, H. Tada, H. Iwabuki, M.K.L. Chuah, T. VandenDriessche, H. Fukuda, A. Kondo, M. Ueda, M. Seno, K. Tanizawa, S. Kuroda, Nanoparticles for the delivery of genes and drugs to human hepatocytes, Nat. Biotechnol. 21 (2003) 885-890.
7. J. Jung, T. Matsuzaki, K. Tatematsu, T. Okajima, K. Tanizawa, S. Kuroda, Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials, J. Control. Release 126 (2008) 255-264.
8. T. Kasuya, J. Jung, R. Kinoshita, Y. Goh, T. Matsuzaki, M. Iijima, N. Yoshimoto, K. Tanizawa, S. Kuroda, Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery, Methods Enzymol. 464 (2009) 147-166.
9. Y. Iwasaki, M. Ueda, T. Yamada, A. Kondo, M. Seno, K. Tanizawa, S. Kuroda, M. Sakamoto, M. Kitajima, Gene therapy of liver tumors with human liver-specific nanoparticles, Cancer Gene Ther. 14 (2007) 74-81. (Pubitemid 44952236)
10. M. Kobayashi, T. Asano, M. Utsunomiya, Y. Itoh, Y. Fujisawa, O. Nishimura, K. Kato, A. Kakinuma, Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: purification and characterization, J. Biotech. 8 (1998) 1-22.
11. T. Ohmura, A. Ohmizu, A. Sumi, W. Ohtani, Y. Uemura, H. Arimura, M. Nishida, Y. Kohama, M. Okabe, T. Mimura, C.M. Heldebrant, Properties of recombinant hepatitis B vaccine, Biochem. Biophys. Res. Commun. 149 (1987) 1172-1178. (Pubitemid 18024669)
12. E. Hardy, E. Martinez, D. Diago, R. Diaz, D. Gonzalez, L. Herrera, Large-scale production of recombinant hepatitis B surface antigen form Pichia pastoris, J. Biotech. 77 (2000) 157-167. (Pubitemid 30055332)
13. M. Belew, Y. Mei, B. Li, J.H. Berglof, J.C. Janson, Purification of recombinant hepatitis B surface antigen (r-HBsAg) produced by transformed CHO cells grown in culture, Bioseparation 1 (1991) 397-408.
14. J. Stephenne, Recombinant versus plasma derived hepatitis B vaccines: issues of safety, immunogenecity and cost-effectiveness, Vaccine 6 (1988) 299-303.
15. T. Yamada, H. Iwabuki, T. Kanno, H. Tanaka, T. Kawai, H. Fukuda, A. Kondo, M. Seno, K. Tanizawa, S. Kuroda, Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein, Vaccine 19 (2001) 3154-3163. (Pubitemid 32324044)
16. Y. Itoh, Y. Fujisawa, Synthesis in yeast of hepatitis B virus surface antigen modified P31 particles by gene modification, Biochem. Biophys. Res. Commun. 141 (1986) 942-948. (Pubitemid 17006139)
17. P.N. Lelie, H.W. Reesink, S.Th. De Jong-van Manen, P.J. Dees, E.E. Reerink-brongers, Immnunogenicity and safety of a plasma-derived heat-inactived hepatitis B vaccine (CLB), Am. J. Epidemiol. 120 (1984) 694-702.
18. K. Sugawara, K. Nishiyama, Y. Ishikawa, M. Abe, K. Sonoda, K. Komatsu, Y. Horikawa, K. Takeda, T. Honda, S. Kuzuhara, Y. Kino, H. Mizokami, K. Mizuno, T. Oka, K. Honda, Development of vero cell-derived inactivated Japanese encephalitis vaccine, Biologicals 30 (2002) 303-314. (Pubitemid 36268966)
19. D. Diminsky, N. Moav, M. Gorecki, Y. Barenholz, Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles, Vaccine 18 (2000) 3-17.
20. I. Ionescu-Matiu, R.C. Kennedy, J.T. Sparrow, A.R. Culwell, Y. Sanchez, J.L. Melnick, G.R. Dreesman, Epitopes associated with a synthetic hepatitis B surface antigen peptide, J. Immunol. 130 (1983) 1947-1952. (Pubitemid 13091663)
21. S. Kuroda, Y. Fujisawa, S. Iino, Y. Akahane, H. Suzuki, Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2+S) protein particles (a third generation vaccine), Vaccine 9 (1991) 163-169.
22. J.A. Gimenez, D.D. Monkovic, M.L. Dekleva, Identification and monitoring of protease activity in recombinant Saccharomyces cerevisiae, Biotechnol. Bioeng. 67 (2000) 245-251.
23. P. Valenzuela, A. Medina, W.J. Rutter, G. Ammerer, B.D. Hall, Synthesis and assembly of hepatitis B virus surface antigen particles in yeast, Nature 298 (1982) 347-351.
24. X. Han, L. Ye, B. Li, G. Bo, W. Cai, Z. Hong, Y. She, Y. Li, L. Kong, Z. Wu, Expression, purification and characterization of the hepatitis B virus entire envelope large protein in Pichia pastoris, Protein Express. Purif. 49 (2006) 168-175. (Pubitemid 44416225)
25. Y. Huang, J. Bi, Y. Zhang, W. Zhou, Y. Li, L. Zhao, Z. Su, A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha, Protein Express. Purif. 56 (2007) 301-310.
26. C.Y. Kang, D.H. Bishop, J.S. Seo, Y. Matsuura, M. Choe, Secretion of particles of hepatitis B surface antigen from insect cells using a baculovirus vector, J. Gen. Virol. 68 (1987) 2607-2613.
27. H.S. Mason, D.M. Lam, C.J. Arntzen, Expression of hepatitis B surface antigen in transgenic plants, Proc. Natl. Acad. Sci. USA 89 (1992) 11745-11749. (Pubitemid 23004720)